The writer is co-director of the Institute of Global Health Innovation at Imperial College London and chair of Pre-emptive Medicine and Health Security Initiative at Flagship Pioneering, the bioplatforms company that founded vaccines maker Moderna
本文作者是倫敦帝國理工學院(Imperial College London)全球健康創新研究所(Institute of Global Health Innovation)聯席主任，以及Flagship Pioneering的“預防醫藥和健康安全倡議”(Preemptive Medicine and Health Security Initiative)主席。Flagship Pioneering是一家生物平臺企業，創建了疫苗制造商莫德納(Moderna)
您已閱讀9%（477字），剩余91%（4601字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。